Εμφάνιση απλής εγγραφής

dc.creatorKatsiki N., Triposkiadis F., Giannoukas A.D., Mikhailidis D.P.en
dc.date.accessioned2023-01-31T08:33:48Z
dc.date.available2023-01-31T08:33:48Z
dc.date.issued2018
dc.identifier10.1097/HCO.0000000000000519
dc.identifier.issn02684705
dc.identifier.urihttp://hdl.handle.net/11615/74641
dc.description.abstractPurpose of review The effects of statin loading before, during or after vascular interventions on cardiovascular and renal outcomes are discussed. Furthermore, the selection of optimal statin type and dose, according to current evidence or guidelines, is considered. The importance of treating statin intolerance and avoiding statin discontinuation is also discussed. Recent findings Statin loading has been shown to beneficially affect cardiovascular outcomes, total mortality and/or contrast-induced acute kidney injury, in patients undergoing vascular procedures such as percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), carotid endarterectomy (CEA), carotid artery stenting, endovascular aneurysm repair, open abdominal aortic aneurysms (AAA) repair and lower extremities vascular interventions. High-dose statin pretreatment is recommended for PCI and CABG according to current guidelines. Statin discontinuation should be avoided during acute cardiovascular events and vascular interventions; adequate measures should be implemented to overcome statin intolerance. Summary Statin loading is an important clinical issue in patients with cardiac and noncardiac vascular diseases, including carotid artery disease, peripheral artery disease and AAA, undergoing vascular interventions. Cardiologists and vascular surgeons should be aware of current evidence and implement guidelines in relation to statin loading, discontinuation and intolerance. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.en
dc.language.isoenen
dc.sourceCurrent Opinion in Cardiologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85050387402&doi=10.1097%2fHCO.0000000000000519&partnerID=40&md5=54f5b861ffeb025b80fe6d9790cf649f
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitoren
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitoren
dc.subjectabdominal aortic aneurysmen
dc.subjectacute kidney failureen
dc.subjectcardiovascular surgeryen
dc.subjectcarotid artery stentingen
dc.subjectcarotid endarterectomyen
dc.subjectcoronary artery bypass graften
dc.subjectdrug megadoseen
dc.subjectdrug withdrawalen
dc.subjectendovascular aneurysm repairen
dc.subjecthumanen
dc.subjectopen surgeryen
dc.subjectpercutaneous coronary interventionen
dc.subjectpriority journalen
dc.subjectReviewen
dc.subjectacute kidney failureen
dc.subjectchemically induceden
dc.subjectpostoperative complicationen
dc.subjectpreoperative careen
dc.subjectAcute Kidney Injuryen
dc.subjectCardiovascular Surgical Proceduresen
dc.subjectHumansen
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitorsen
dc.subjectPostoperative Complicationsen
dc.subjectPreoperative Careen
dc.subjectLippincott Williams and Wilkinsen
dc.titleStatin loading in cardiovascular surgery: Never too early to treaten
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής